Bausch+Lomb ($BLCO), a contact lens supplier, is exploring a sale to address concerns raised by its lenders like Apollo ...

Bausch + Lomb is exploring a sale as its parent company, Bausch Health, faces significant debt and creditors' opposition to a ...

Bausch Health retained an 88 per cent shareholding in the eye care subsidiary after listing the group in 2022. But it planned ...

Bausch + Lomb (BLCO) stock will be in focus as company is exploring a sale to address concerns raised over its separation ...

Bausch + Lomb is assessing interest from potential buyers as a way around the roadblock, the FT wrote. The company had a market cap of $6.27 billion on Monday.

SIMPLIFY YOUR CONTACT LENS CARE: Go beyond clean and keep your contacts feeling clean and comfortable with renu contact solution. renu FROM BAUSCH + LOMB: renu Advanced Formula is our newest ...

Consumer medical giant Bausch + Lomb may be preparing to sell off its eye care business, which would include contact lens ...

Bausch + Lomb is working with advisers from Goldman Sachs to test interest from possible buyers, the Financial Times reported ...

Health-care companies rose amid deal intrigue. Bausch + Lomb rallied after The Financial Times reported that the maker of contact lenses and other optical equipment was seeking to sell itself to ...

Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues Bausch + Lomb is exploring a sale as its parent company, Bausch Health ...

Bausch + Lomb ... after listing Bausch + Lomb in 2022 but struggled to execute the full separation due to concerns about solvency after the split. The world’s largest contact lens supplier ...